ea0081rc10.8 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022
, Favacchio Giuseppe
, Mazziotti Gherardo
, Lania Andrea
, Mirani Marco
RCTs and real-life studies have shown the efficacy of GLP-1 RAs on weight loss, glycemic outcomes, and prevention of cardiovascular (CV) events, but long-term data are lacking. This was a retrospective cohort study of 253 patients with a first prescription of a GLP-1 RA between 2009 and 2016 and a minimum follow-up of 5 years. The endpoints of the study were weight and glycemic outcomes. Secondary endpoints were the occurrence of renal and CV events, comparing patients with GL...